Sector consensus Arcus Biosciences, Inc.

Equities

Delayed Nyse Other stock markets 20:55:35 11/09/2024 BST			5-day change	1st Jan Change
16.86 ^USD	+1.05%		+3.55%	-11.52%

09-04	Transcript : Arcus Biosciences, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 04:50 PM
08-27	Arcus Biosciences Gets Up to $250 Million Term Loan Facility From Hercules Capital	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
ARCUS BIOSCIENCES, INC.	33.13	+98.59%	8
LONZA GROUP AG	623.67	+13.93%	21
IQVIA HOLDINGS INC.	276.53	+17.57%	21
ALNYLAM PHARMACEUTICALS, INC.	283.17	+10.52%	27
MODERNA, INC.	125.71	+58.57%	21
CELLTRION, INC.	246,777.78	+26.04%	18
ICON PUBLIC LIMITED COMPANY	365.40	+30.28%	15
UNITED THERAPEUTICS CORPORATION	350.71	+2.41%	13
BIO-TECHNE CORPORATION	82.55	+11.89%	13
QIAGEN N.V.	50.97	+11.05%	17
MEDPACE HOLDINGS, INC.	406.91	+24.14%	9
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	224.07	+17.92%	17
REVOLUTION MEDICINES, INC.	59.21	+42.24%	14
TEMPUS AI, INC	46.00	+2.11%	8
BACHEM HOLDING AG	82.83	+9.50%	6
IONIS PHARMACEUTICALS, INC.	62.67	+47.84%	25
HANGZHOU TIGERMED CONSULTING CO., LTD	69.82	+42.73%	16
BLUEPRINT MEDICINES CORPORATION	127.35	+48.10%	17
PHARMARON BEIJING CO., LTD.	22.63	+13.22%	12
Average	13,161.64	+27.82%	16
Weighted average by Cap.	24,446.89	+23.14%	18